Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?

被引:89
作者
Hilfiker, Andres [1 ]
Kasper, Cornelia [2 ]
Hass, Ralf [3 ]
Haverich, Axel [1 ,4 ]
机构
[1] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs L, D-30625 Hannover, Germany
[2] Leibniz Univ Hannover, Inst Tech Chem, Hannover, Germany
[3] Hannover Med Sch, Dept Obstet & Gynecol, Lab Biochem & Tumor Biol, D-30625 Hannover, Germany
[4] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, D-30625 Hannover, Germany
关键词
Tissue engineering; MSC; Connective tissue; Transplantation; HUMAN UMBILICAL-CORD; MARROW STROMAL CELLS; NEURON-LIKE CELLS; VERSUS-HOST-DISEASE; BONE-MARROW; IN-VITRO; ADIPOSE-TISSUE; HEART-VALVES; VASCULAR GRAFTS; CLINICAL-APPLICATION;
D O I
10.1007/s00423-011-0762-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Transplantation surgery suffers from a shortage of donor organs worldwide. Cell injection and tissue engineering (TE), thus emerge as alternative therapy options. The purpose of this article is to review the progress of TE technology, focusing on mesenchymal stem cells (MSC) as a cell source for artificial functional tissue. MSC from many different sources can be minimally invasively harvested: peripheral blood, fat tissue, bone marrow, amniotic fluid, cord blood. In comparison to embryonic stem cells (ESC), there are no ethical concerns; MSC can be extracted from autologous or allogenic tissue and cause an immune modulatory effect by suppressing the graft-versus-host reaction (GvHD). Furthermore, MSC do not develop into teratomas when transplanted, a consequence observed with ESC and iPS cells. MSC as multipotent cells are capable of differentiating into mesodermal and non-mesodermal lineages. However, further studies must be performed to elucidate the differentiation capacity of MSC from different sources, and to understand the involved pathways and processes. Already, MSC have been successfully applied in clinical trials, e.g., to heal large bone defects, cartilage lesions, spinal cord injuries, cardiovascular diseases, hematological pathologies, osteogenesis imperfecta, and GvHD. A detailed understanding of the behavior and homing of MSC is desirable to enlarge the clinical application spectrum of MSC towards the in vitro generation of functional tissue for implantation, for example, resilient cartilage, contractile myocardial replacement tissue, and bioartificial heart valves.
引用
收藏
页码:489 / 497
页数:9
相关论文
共 111 条
[71]   Effects of Cell Seeding and Cyclic Stretch on the Fiber Remodeling in an Extracellular Matrix-Derived Bioscaffold [J].
Nguyen, Tan D. ;
Liang, Rui ;
Woo, Savio L-Y. ;
Burton, Shawn D. ;
Wu, Changfu ;
Almarza, Alejandro ;
Sacks, Michael S. ;
Abramowitch, Steven .
TISSUE ENGINEERING PART A, 2009, 15 (04) :957-963
[72]   Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration [J].
Oh, Seh-Hoon ;
Witek, Rafal P. ;
Bae, Si-Hyun ;
Zheng, Donghang ;
Jung, Youngmi ;
Piscaglia, Anna C. ;
Petersen, Bryon E. .
GASTROENTEROLOGY, 2007, 132 (03) :1077-1087
[73]   Cartilaginous tissue formation from bone marrow cells using rotating wall vessel (RWV) bioreactor [J].
Ohyabu, Yoshimi ;
Kida, Naoko ;
Kojima, Hiroko ;
Taguchi, Tetsushii ;
Tanaka, Junzo ;
Uemura, Toshimasa .
BIOTECHNOLOGY AND BIOENGINEERING, 2006, 95 (05) :1003-1008
[74]   Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells [J].
Panepucci, RA ;
Siufi, JLC ;
Silva, WA ;
Proto-Siquiera, R ;
Neder, L ;
Orellana, M ;
Rocha, V ;
Covas, DT ;
Zago, MA .
STEM CELLS, 2004, 22 (07) :1263-1278
[75]   Novel sources of fetal stem cells: where do they fit on the developmental continuum? [J].
Pappa, Kalliopi I. ;
Anagnou, Nicholas P. .
REGENERATIVE MEDICINE, 2009, 4 (03) :423-433
[76]   Mesenchymal Stem Cells as Therapeutics [J].
Parekkadan, Biju ;
Milwid, Jack M. .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 12, 2010, 12 :87-117
[77]   The use of mesenchymal stem cells for chondrogenesis [J].
Pelttari, Karoliina ;
Steck, Eric ;
Richter, Wiltrud .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2008, 39 :S58-S65
[78]   Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy [J].
Perin, EC ;
Dohmann, HFR ;
Borojevic, R ;
Silva, SA ;
Sousa, ALS ;
Silva, GV ;
Mesquita, CT ;
Belém, L ;
Vaughn, WK ;
Rangel, FOD ;
Assad, JAR ;
Carvalho, AC ;
Branco, RVC ;
Rossi, MID ;
Dohmann, HJF ;
Willerson, JT .
CIRCULATION, 2004, 110 (11) :II213-II218
[79]   Multilineage potential of adult human mesenchymal stem cells [J].
Pittenger, MF ;
Mackay, AM ;
Beck, SC ;
Jaiswal, RK ;
Douglas, R ;
Mosca, JD ;
Moorman, MA ;
Simonetti, DW ;
Craig, S ;
Marshak, DR .
SCIENCE, 1999, 284 (5411) :143-147
[80]  
Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI 10.1089/ten.TEB.2009.0705